Latest filing published 21 Nov 2013 for Vanda Pharmaceuticals Inc., €26k.
Insider track record
No signal scores available.
Robert Repella: trading record in brief
All filings by Robert Repella on record concern Vanda Pharmaceuticals Inc. The record holds 8 filings, for trades running from 14 February 2013 to 21 November 2013.
The open-market record consists of 3 sales worth €959k, with no purchase. Besides market trades, the filings include 5 option exercises.
The record was last updated on 21 November 2013 with an open-market sale (€26k) in Vanda Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Repella
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,885 shares@ US$12.07Common StockSEC:0001209191-13-053649:0
- 40,515 shares@ US$5.90Common StockSEC:0001209191-13-053649:1
- 40,515 shares@ US$11.89Common StockSEC:0001209191-13-053649:2
- 23,040 shares@ US$5.90Common StockSEC:0001209191-13-053649:3
- 34,570 shares@ US$3.12Common StockSEC:0001209191-13-053649:4
- 64,100 shares@ US$12.12Common StockSEC:0001209191-13-053649:5
- 9,375 sharesCommon StockSEC:0001209191-13-038505:0
- 15,000 sharesCommon StockSEC:0001209191-13-009931:0
8 of 8 declarations
